PBE vs. MARB ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to First Trust Merger Arbitrage ETF (MARB)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$70.99
Average Daily Volume
6,407
30
MARB
First Trust Merger Arbitrage ETF
MARB Description
The investment seeks to provide investors with capital appreciation. Under normal market conditions, the fund seeks to achieve its investment objective by establishing long and short positions in the equity securities of companies that are involved in a publicly-announced significant corporate event, such as a merger or acquisition. It's portfolio may include equity securities issued by U.S. and non-U.S. companies, including American Depositary Receipts (ADRs), and derivatives, including total return swaps. The fund may invest in securities issued by small, mid and large capitalization issuers. It is non-diversified.Grade (RS Rating)
Last Trade
$19.71
Average Daily Volume
6,873
35
Performance
Period | PBE | MARB |
---|---|---|
30 Days | 2.37% | -0.71% |
60 Days | -0.19% | -1.20% |
90 Days | 3.42% | -1.72% |
12 Months | 31.49% | -0.67% |
0 Overlapping Holdings
Symbol | Grade | Weight in PBE | Weight in MARB | Overlap |
---|
PBE Overweight 30 Positions Relative to MARB
Symbol | Grade | Weight | |
---|---|---|---|
UTHR | B | 5.84% | |
ILMN | C | 5.74% | |
AMGN | F | 4.95% | |
ALNY | D | 4.92% | |
BIIB | F | 4.23% | |
NBIX | C | 4.1% | |
EXEL | B | 3.82% | |
XNCR | B | 3.74% | |
MNKD | C | 3.7% | |
BMRN | F | 3.69% | |
INCY | B | 3.45% | |
REGN | F | 3.43% | |
TGTX | B | 3.38% | |
CPRX | B | 3.17% | |
VCYT | B | 3.09% | |
ACAD | C | 3.04% | |
NTRA | B | 3.03% | |
PTGX | C | 2.97% | |
BPMC | B | 2.94% | |
TECH | C | 2.9% | |
VCEL | B | 2.74% | |
HALO | B | 2.62% | |
RGEN | D | 2.61% | |
QGEN | F | 2.58% | |
BCRX | C | 2.56% | |
OPK | C | 2.5% | |
COLL | F | 2.31% | |
NVAX | F | 2.17% | |
CDNA | D | 2.02% | |
MYGN | F | 1.72% |
PBE Underweight 35 Positions Relative to MARB
Symbol | Grade | Weight | |
---|---|---|---|
HTLF | B | -6.92% | |
HCP | A | -5.6% | |
EDR | C | -4.92% | |
AMED | F | -4.79% | |
ACI | C | -4.61% | |
AXNX | A | -4.2% | |
NAPA | B | -4.0% | |
DFS | B | -3.92% | |
B | B | -3.79% | |
JNPR | C | -3.69% | |
ANSS | B | -3.62% | |
EVRI | A | -3.48% | |
K | A | -3.27% | |
ESGR | C | -3.18% | |
CTLT | C | -3.14% | |
VZIO | C | -3.05% | |
HES | C | -3.03% | |
LBPH | A | -2.77% | |
SRCL | B | -2.68% | |
MGRC | B | -2.65% | |
FYBR | D | -2.62% | |
CHX | D | -2.5% | |
ENV | B | -2.37% | |
SRDX | C | -2.23% | |
RCM | B | -2.07% | |
MRO | B | -1.97% | |
IBTX | B | -1.94% | |
WSC | F | --0.98% | |
SSB | B | --1.96% | |
COP | C | --1.99% | |
SNPS | B | --2.09% | |
CVX | B | --3.53% | |
SLB | D | --3.78% | |
COF | B | --4.43% | |
UMBF | B | --7.15% |
PBE: Top Represented Industries & Keywords
MARB: Top Represented Industries & Keywords